|
|
Volumn 17, Issue SUPPL. B, 1996, Pages 17-20
|
|
Beta-blockers in heart failure - The evidence from clinical trials
|
|
Author keywords
Beta blockers; Clinical trials; Heart failure
|
|
Indexed keywords
ACEBUTOLOL;
ALPRENOLOL;
BETA 1 ADRENERGIC RECEPTOR;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUCINDOLOL;
CARVEDILOL;
LABETALOL;
METOPROLOL;
NEBIVOLOL;
NORADRENALIN;
PROPRANOLOL DERIVATIVE;
VASODILATOR AGENT;
XAMOTEROL;
BETA ADRENERGIC RECEPTOR BLOCKING;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
EXERCISE TOLERANCE;
HEART DILATATION;
HEART FAILURE;
HEART STROKE VOLUME;
HEART VENTRICLE FUNCTION;
HEMODYNAMICS;
HUMAN;
NORADRENALIN BLOOD LEVEL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECEPTOR DOWN REGULATION;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
SURVIVAL RATE;
VASODILATATION;
|
|
EID: 0029997317
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/eurheartj/17.suppl_b.17 Document Type: Conference Paper |
|
Times cited : (18)
|
|
References (0)
|
